eli lilly glp-1 agonist Lilly's Next-Generation GLP-1R Naperiglipron—Structure Revealed GLP-1 Competitive Environment - Citrini

JAMA Neurol 76:10881098

Summary of included studies regarding the adverse psychiatric outcomes associated with GLP-1-RAs)

doi: 10.1037 [DOI] [PubMed] [Google Scholar] 40.El-Osta A, Sasco ER, Barbanti E, Webber I, Alaa A, Karki M, Asmar MLE, Idriss H, Almadi M, Massoud F, Alboksmaty A, Majeed A

However, most insurance companies will at least partially cover the cost of surgery, as long as certain criteria are met, such as BMI requirements or a documented history of weight loss efforts

Starting with a lower dose and gradually increasing (dose titration) helps minimise these symptoms

128 caution is still recommended in patients with predisposing risk factors or a history of pancreatitis